UK oncology healthcare companies bring innovation to India

The delegation, identified by Healthcare UK as some of the UK’s most innovative in oncology healthcare, will attend the 2nd Indian Cancer Congress in Bengaluru from 9 to 12 November. They will also visit the India-UK Healthcare Forum 2017 in Mumbai on 13 November.
India is expected to see 1.73 million new cancer cases by 2020 (source: National Cancer Registry). Oral, breast, lung, cervical cancers are among the leading causes of deaths in the country. India requires new technology in every aspect of this disease - from genetics to early detection, new treatment protocols and medical equipment.
India and the UK share common goals with regard to cancer treatment and research. The UK is at the forefront of cancer research, as well as the development and introduction of new technologies.
The UK’s National Health Service (NHS) has a cancer strategy to improve cancer prevention, diagnosis, treatment and end-of-life care. The NHS and UK companies have compelling offers in cancer for overseas health systems covering:
  • advanced laboratory diagnostics including the latest genomic testing
  • provision of leading edge cancer services
  • development of the latest clinical protocols to achieve high quality clinical outcomes
  • R&D collaborations with potential for longer term partnerships
  • unmatched data assets to underpin research
  • the full range of education and training in cancer for doctors, nurses and technical staff.
The NHS in England is moving ahead on the path laid out by its Five Year Forward View.
Commenting on the visit, Dominic McAllister, British Deputy High Commissioner Bengaluru said:
Indian government wants to provide universal healthcare and adopt ‘smart healthcare’ to support sustainable and world-class services for the Indian people. The UK has the expertise and technology to support every aspect of India’s healthcare systems and services. There is no better time than now for the UK and India to partner and shape the future of Indian healthcare.
I hope that through our delegation, we will help forge some ground-breaking partnerships in overcoming the cancer challenge in India. We are also helping Indian business access the best of British advanced technology in healthcare by taking Indian delegations across the UK as a part of the India-UK Future TECH month. This is a very good platform of both UK and India to work together for improved healthcare in India.
As the trade mission travels to the Bengaluru and Mumbai, the Indian companies will get an opportunity to network with UK healthcare firms and find out about opportunities for collaboration. The UK has an unmatched combination of clinical, technological and academic expertise. Indian companies can explore this and more during their interactions with the visiting mission.
The trade mission coincides with the India-UK Future TECH month showcasing the very best of the UK’s strengths in technology and innovation across data analytics, Internet of Things, ICT services and a wide variety of sectors. The mission will have a varied and influential Indian audience, including buyers, investors and central and state level government.
The Department for International Trade India is taking more than 60 companies across 10 sectors across a tour of business hubs in the North - Manchester, Liverpool, in the Midlands -Birmingham, Leicester, Coventry and in London with the primary objective of inspiring new business and new tech collaboration.


Popular posts from this blog

EMA Recommends Extension of Indications for Ramucirumab

Dr. Hootie Warren takes helm of Fred Hutch Global Oncology

Merck announces positive event-free survival data from phase 3 KEYNOTE-522 study of Keytruda to treat triple-negative breast cancer